Safety advice BPC 157 is not an approved treatment for most medical conditions, and quality and sterility standards vary by supplier
Key areas of active scientific investigation utilizing this dual-action research blend include: Accelerated Angiogenesis and Endothelial Migration: Modeling the structural formation of new microvascular networks
It depends on what you are treating
Involvement of ERK1/2 pathway in BPC-157-induced cell proliferation, migration, and tube formation To explore whether the ERK1/2, JNK, or p38 pathway was involved in BPC-157-induced cell proliferation, migration, and tube formation, PD98059 (ERK1/2 inhibitor), SP600125 (JNK inhibitor), and SB203580 (p38 inhibitor) were used
The underconsumed and underappreciated essential nutrient
Side effects and safety profile AOD 9604 is generally well-tolerated